SEC Form D · Amendment · filed September 18, 2020
Escient Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Peter Hirth · San Diego, CADirectorMarcus Boehm · San Diego, CAExecAndrew Schwab · San Francisco, CADirectorJeenjoo Kang · San Francisco, CADirectorCharles Zuker · San Diego, CADirectorJason Hafler · Cambridge, MADirectorKevin Raidy · New York, NYDirectorAlain Baron · San Diego, CAExec · DirectorKathleen Glaub · San Diego, CADirectorFrank Gadams · NORFOLK, VADirectorBijel Doshi · Reno, NVDirectorAbel Godfrey · Luxembourg, LuxembourgDirectorMike P. Vanhorn · Joplin, MOExec · DirectorRandy S. Hurwitz · Los Angeles, CADirectorAnton Baranchuk · San Carlos, CADirectorMatt G. Price · Cincinnati, OHExecKevin Leary · Reno, NVDirectorShane Haag · Baton Rouge, LADirectorGilbert G. Schneider · VANCOUVER, British Columbia, CanadaDirectorJohn Ryan · Wallace, IDExecJoaquim Trias · Natick, MADirectorMatthew Boutte · Fair Oaks Ranch, TXDirectorCharles E. Smith · Fair Oaks Ranch, TXDirectorChristopher Watters · Austin, TXExec · DirectorJay Stevens · Marriottsville, MDDirectorMatthew Eitner · New York, NYDirectorPatrick Gallagher · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗